[CYCC] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -4.16%
YoY- -18.67%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,091 -4,165 -3,182 -2,537 -2,452 -1,510 -2,752 69.91%
Tax -964 -687 -378 -281 -286 -290 -449 66.50%
NP -5,127 -3,478 -2,804 -2,256 -2,166 -1,220 -2,303 70.57%
Tax Rate - - - - - - - -
Total Cost 5,127 3,478 2,804 2,256 2,166 1,220 2,303 70.57%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 -47,711,417,389,824.74 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.56 -0.50 -0.57 -0.46 -0.56 -1.42 -2.68 -64.82%
EPS Diluted -0.56 -0.50 -0.57 -0.46 -0.56 -1.42 -2.68 -64.82%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.